Australia's largest stock trading and investment forum Australia's #1 stock forum

VLA

0.00%

$1.75 viralytics limited

Ann: Annual Report to shareholders, page-17

First 17 Last

Share
Profile

Follow
Lopez

12,188 Posts.

1084

25/10/17

10:54

Post #: 28174515
Share

Originally posted by kmsmith ↑

Morning all,
I could not agree more that owning VLA shares has been a real test of patience. There are so many things I do not understand. If we owned technology that meant a car could drive twice the distance on a tank of petrol, I imagine we could sell it to one of the car manufacturers in about 8 minutes. VLA have a product that seems to mean the effectiveness of other products is increased just as much. In something so much more important than fuel efficiency. Yet the result is …. we do some more trials.

In a sense it is hard to blame Management because, with podium presentations, VLA just must be on the radar of more than one large pharma. They cannot force them to make offers. Why they would not be clamouring at the door (and already make significant offers) is mystifying.

The one positive I can take from recent releases is the comment that they are ‘Planning now for a pivotal trial’. I assume this is saying that if absolutely necessary we will try for a Phase 3 trial ourselves. NEU have done similar by targeting a gut-wrenching conditions known as Retts. As the numbers are small numbers for a Phase 3 are much smaller than most Phase 3 trials. At one stage I seem to recall VLA talking about trials aimed at those patients who had failed Keytruda etc. I wonder if we get a much smaller target might mean we can have a smaller Phase 3 trial? I am no expert though. Any more knowledgeable posts would be appreciated.

Either way, with Health funds now on the register who can all see the potential, you would think Phase 3 must be a possibility. How good would that be? Probably water down holdings significantly, but if then we get a much higher % of Sales it would still be a great outcome.

In previous years, I have made it to the AGM (10 years+ I would think) and posted a summary of proceedings. This year I will be away so hopefully someone else (Bripoz, believe you said you were going??) can give a summary this year.

Trust you all have a magnificent day!

Rgds
KMS

Expand

Hi Km,
Malcolm posted an article on twitter Focus on Oncology.
I think that sums up his game plan.
The more convincing the Data the larger the deal.
To my mind it's getting very close.
If the share price was $2 i doubt the board would be so disgruntled.
Also interesting that in the latest report Malcolm went out of his way to tell us a few of our competitors have fallen by the wayside.
By the way VLA have a line of communication so if you have a beef email them.
Aloha.

VLA Price at posting: 81.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

TVN

Tivan and EARTH AI gear up to commence fresh drilling at Sandover lead-silver project, NT

The Big Deal: Free-to-air TV swings the axe, but will it be enough as enormous sports deal bills loom?

RHI

Red Hill Minerals Signs $6.5 Million Agreement with Peel Mining to Explore Curnamona Project, NSW

KGL

KGL sniffs 19% Cu from drilling at Rockface play in NT

CUV

British study shows Clinuvel drug effective on DNA of UV-damaged skin